Upcoming event
40th Annual EAU Congress
Back

Tag: EAU22

ESOU Online: EAU22 highlights in prostate cancer

Overall survival with darolutamide versus placebo in combination with androgen-deprivation therapy and docetaxel by stratification factors in the phase 3 ARASENS Trial – Discusssant

18F-DCPyL PSMA PET/CT and mpMRI prostate: A prospective comparison of ability to diagnose and locate prostate cancer (PEDAL study)

18F-DCPyL PSMA PET/CT and mpMRI prostate: A prospective comparison of ability to diagnose and locate prostate cancer (PEDAL study) – Discussant

Overall Survival With Darolutamide Versus Placebo in Combination With Androgen-deprivation Therapy and Docetaxel by Stratification Factors in the Phase 3 ARASENS Trial